VISTAGEN THERAPEUTICS, INC. Capital Leases, Net Investment in Direct Financing Leases, Initial Direct Costs
VISTAGEN THERAPEUTICS, INC. (VTGN) had Capital Leases, Net Investment in Direct Financing Leases, Initial Direct Costs of $25.00 thousand as of 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesNetInvestmentInDirectFinancingLeasesInitialDirectCosts · last filed 2014-02-14
- 2013-12-31: Capital Leases, Net Investment in Direct Financing Leases, Initial Direct Costs $25.00K.
- 2013-09-30: Capital Leases, Net Investment in Direct Financing Leases, Initial Direct Costs $25.00K.
- 2013-06-30: Capital Leases, Net Investment in Direct Financing Leases, Initial Direct Costs $25.00K.
| Period end | Capital Leases, Net Investment in Direct Financing Leases, Initial Direct Costs |
|---|---|
| 2013-12-31 | $25.00K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $25.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $25.00K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |